Logo image of HBP

HUTTIG BUILDING PRODUCTS INC (HBP) Stock Fundamental Analysis

NASDAQ:HBP - US4484511047 - Common Stock

10.7
+0.02 (+0.19%)
Last: 5/2/2022, 8:00:01 PM
10.7
0 (0%)
After Hours: 5/2/2022, 8:00:01 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to HBP. HBP was compared to 50 industry peers in the Trading Companies & Distributors industry. HBP has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, HBP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HBP was profitable.
HBP Yearly Net Income VS EBIT VS OCF VS FCFHBP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M 40M -40M

1.2 Ratios

Industry RankSector Rank
ROA 15.66%
ROE 52.09%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HBP Yearly ROA, ROE, ROICHBP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 -40

1.3 Margins

Industry RankSector Rank
OM 5.57%
PM (TTM) 5.17%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HBP Yearly Profit, Operating, Gross MarginsHBP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 5 10 15 20

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for HBP has been increased compared to 1 year ago.
Compared to 1 year ago, HBP has an improved debt to assets ratio.
HBP Yearly Shares OutstandingHBP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
HBP Yearly Total Debt VS Total AssetsHBP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

An Altman-Z score of 5.07 indicates that HBP is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.75 indicates that HBP is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF N/A
Altman-Z 5.07
ROIC/WACCN/A
WACCN/A
HBP Yearly LT Debt VS Equity VS FCFHBP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M 100M

2.3 Liquidity

A Current Ratio of 2.05 indicates that HBP has no problem at all paying its short term obligations.
A Quick Ratio of 0.95 indicates that HBP may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 0.95
HBP Yearly Current Assets VS Current LiabilitesHBP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

HBP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 4719.94%, which is quite impressive.
HBP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.53% yearly.
Looking at the last year, HBP shows a quite strong growth in Revenue. The Revenue has grown by 18.36% in the last year.
The Revenue has been growing slightly by 5.61% on average over the past years.
EPS 1Y (TTM)4719.94%
EPS 3YN/A
EPS 5Y21.53%
EPS Q2Q%2600%
Revenue 1Y (TTM)18.36%
Revenue growth 3Y3.76%
Revenue growth 5Y5.61%
Sales Q2Q%24.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.77%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HBP Yearly Revenue VS EstimatesHBP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B
HBP Yearly EPS VS EstimatesHBP Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 0.02 0.04 0.06 0.08

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.37, the valuation of HBP can be described as very cheap.
HBP's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.07.
Industry RankSector Rank
PE 6.37
Fwd PE N/A
HBP Price Earnings VS Forward Price EarningsHBP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.31
HBP Per share dataHBP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.3
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HBP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HUTTIG BUILDING PRODUCTS INC

NASDAQ:HBP (5/2/2022, 8:00:01 PM)

After market: 10.7 0 (0%)

10.7

+0.02 (+0.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)03-02 2022-03-02/amc
Earnings (Next)05-17 2022-05-17/amc
Inst Owners0.03%
Inst Owner Change0%
Ins Owners5.05%
Ins Owner Change0%
Market Cap292.43M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.37
Fwd PE N/A
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B 3.14
P/tB N/A
EV/EBITDA 6.31
EPS(TTM)1.68
EY15.7%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS34.31
BVpS3.41
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.3
Profitability
Industry RankSector Rank
ROA 15.66%
ROE 52.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 5.57%
PM (TTM) 5.17%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover3.03
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.05
Quick Ratio 0.95
Altman-Z 5.07
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4719.94%
EPS 3YN/A
EPS 5Y21.53%
EPS Q2Q%2600%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.36%
Revenue growth 3Y3.76%
Revenue growth 5Y5.61%
Sales Q2Q%24.81%
Revenue Next Year8.77%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A